Balyasny Asset Management

Balyasny Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Balyasny Asset Management’s Portfolio MRNS Stock Details MRNS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$17.6K	Buy
2024 Q2	–	Sell
2024 Q1	$7.68M	Buy
2023 Q4	–	Sell
2023 Q3	$128K	Buy
2023 Q2	–	Sell
2023 Q1	$120K	Buy
2018 Q4	–	Sell
2018 Q3	$2.1M	Buy
2018 Q1	–	Sell
2017 Q4	$8.17M	Buy